C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2004
12/15/2004	CN1555370A Process for the preparation of 5-substituted isobenzofurans
12/15/2004	CN1555369A Method for producing benzofuran derivative
12/15/2004	CN1555368A Process for preparing 2,5-diformylfuran from carbohydrates
12/15/2004	CN1555361A Butyric acid derivatives
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004	CN1180083C Cytochrome C and its gene
12/15/2004	CN1179957C Method for production of benzofuranone oximes
12/15/2004	CN1179956C Intermediate for preparing substituted dioxazine
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831182 Gas-phase hydrogenation of C4-dicarboxylic acids and/or their derivatives over a catalyst based on copper oxide to give substituted or unsubstituted gamma-butyrolactone and/or tetrahydrofuran
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004	WO2004106320A1 Process for producing optically active lactone
12/09/2004	WO2004106318A1 The extract method of cis-ligustilide and the pharmaceutical use of the same
12/09/2004	WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004	WO2004106316A1 Method for producing alkoxylated 2,5-dihydrofuran or tetra-1,1,4,4-alkoxylated but-2-ene derivatives
12/09/2004	WO2004106315A2 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
12/09/2004	WO2004106289A1 Protease inhibitors
12/09/2004	US20040249175 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
12/09/2004	US20040249172 Process for the preparationof prostaglandins and analogues thereof
12/09/2004	US20040249171 Obtaining crude succinic anhydride by a hydrogenation reaction of maleic anhydride used as a raw material; and then purifying the crude succinic anhydride by distillation
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040248963 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders
12/09/2004	US20040248952 Novel bicyclic compounds and compositions
12/09/2004	US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	DE10323817A1 Verfahren zur Herstellung von Phthalsäureanhydrid A process for preparing phthalic anhydride
12/09/2004	DE10322191A1 N-sulfonylierte Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung N-sulfonylated amino acid derivatives, processes for their preparation and their use
12/09/2004	CA2527691A1 Condensed ring compound
12/09/2004	CA2527197A1 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483254A1 Resistance-repellent retroviral protease inhibitors
12/08/2004	EP1483253A1 An antimicrobial agent
12/08/2004	EP1483252A1 Method for purifying tetrahydrofuran by distillation
12/08/2004	EP1483238A1 Method for the simultaneous production of tetrahydrofurans and pyrrolidones
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482925A1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl!-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1412341B1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1286763B1 Counterflow reactor with a bundle of contact tubes
12/08/2004	EP1216227B1 Preparation of sulfonyl imine compounds
12/08/2004	EP0915868B1 Carbanilides used as pesticides
12/08/2004	CN1553915A Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
12/08/2004	CN1553895A Taxol enhancer compounds
12/08/2004	CN1553894A Taxol enhancer compounds
12/08/2004	CN1553893A Synthesis of taxol enhancers
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553887A A method for isolating phenolic substances or juvabiones from wood comprising knotwood
12/08/2004	CN1552702A Medicinal use and extraction of cis-ligusticum lactone
12/08/2004	CN1178934C Benzofurane derivatives
12/08/2004	CN1178933C Photochromic diarylheterocycloethylene compounds sensitive to blue light and its preparing process and usage
12/08/2004	CN1178932C Amide derivatives
12/07/2004	US6828448 2-butyl-5-(methanesulfonamido)benzofuran; preparation of dronedarone
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828444 Process for use in 11-oxa prostaglandin synthesis
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/02/2004	WO2004103951A1 Method for producing an optically active nitro compound
12/02/2004	WO2004103944A1 Method for producing phthalic anhydride
12/02/2004	WO2004103941A2 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242724 Acid decomposable compound
12/02/2004	US20040242680 Chemical intermediate for rofecoxib, cyclooxygenase inhibitor
12/02/2004	US20040242678 Apolipo protein e secretion promoters
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
12/02/2004	US20040242585 Acylsulfamide inhibitors of factor VIIa
12/02/2004	US20040242584 Muscarinic agonists
12/02/2004	US20040237214 Aniline, thiophene, furan, thiazole, triazole or pyrazole dye couplers; hair dyes with improved colorfastness, washfastness and photostability
12/02/2004	DE10320326A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
12/02/2004	CA2526027A1 Process for making spirolactone compounds
12/02/2004	CA2525310A1 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481959A1 Process for the preparation of lactones and aromatic hydroxycarboxylic acids
12/01/2004	EP1481679A1 Antidepressant
12/01/2004	EP1481670A1 Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004	EP1480944A2 Substituted aryl ketones
12/01/2004	EP1412340A4 Process for the preparation of citalopram hydrobromide
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0975586B1 Oxime compounds, their use, and intermediates for their production
12/01/2004	CN1551875A M-aminophenol derivatives and coloring agents containing them
12/01/2004	CN1550497A Preparation of citalopram
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177842C New agarofuran derivatives and their prepn. medicine composition and use as medicine
12/01/2004	CN1177841C Treatment of crude phthalic anhydride
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825363 A dibenzofuranonylium methylate derivatives zwitterions, obtained from a cyclization reaction; maximum absorption wavelength, thermal stability and good solubility in solvents

1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 472